Gustavo Pacheco-Rodríguez1, Wendy K Steagall1, Leigh Samsel2, Pradeep K Dagur2, J Philip McCoy2, Ilker Tunc3, Mehdi Pirooznia3, Ji-An Wang4, Thomas N Darling4, Joel Moss5. 1. Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda. 2. Flow Cytometry Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda. 3. The Bioinformatics and Computational Biology Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda. 4. Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, MD. 5. Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda. Electronic address: mossj@nhlbi.nih.gov.
Abstract
BACKGROUND: Lymphangioleiomyomatosis (LAM) is a destructive metastasizing neoplasm of the lung characterized by proliferation of LAM cells in specialized lung nodules. LAM cells are characterized by expression of the prometastatic and cancer-initiating hyaluronan receptor CD44v6, and loss of heterozygosity (LOH) of TSC1 and TSC2. The circulating neoplastic LAM cells are thought to be involved in metastasis. Because LAM cells display properties of neoplastic, metastatic, and stem cell-like cancer cells, we hypothesized that elevated aldehyde dehydrogenase (ALDH) activity, characteristic of cancer and stem cells, is a property of LAM cells. METHODS: We performed an in silico search of ALDH genes in microdissected LAM lung nodules. To identify circulating LAM cells, we osmotically removed red blood cells from whole blood to obtain peripheral blood mononuclear cells, which were then sorted by fluorescence-activated cell sorting based on their level of ALDH activity. RESULTS: Microdissected LAM lung nodules possess a distinctive ALDH gene profile. The cell subpopulation with high ALDH activity, isolated from circulating cells, possessed TSC2 LOH in 8 of 14 patients with LAM. Approximately 60% of the circulating cells with high ALDH activity expressed CD44v6. Cells with TSC2 LOH from patients with LAM and LAM/TSC exhibited different properties in different body locations, but all cell types showed high ALDH activity. CONCLUSIONS: This new procedure allows for isolation of circulating LAM cells from cultured cells, blood, and chylous effusions and shows that circulating LAM cells are heterogeneous with neoplastic, metastatic, and cancer-stem cell-like properties.
BACKGROUND:Lymphangioleiomyomatosis (LAM) is a destructive metastasizing neoplasm of the lung characterized by proliferation of LAM cells in specialized lung nodules. LAM cells are characterized by expression of the prometastatic and cancer-initiating hyaluronan receptor CD44v6, and loss of heterozygosity (LOH) of TSC1 and TSC2. The circulating neoplastic LAM cells are thought to be involved in metastasis. Because LAM cells display properties of neoplastic, metastatic, and stem cell-like cancer cells, we hypothesized that elevated aldehyde dehydrogenase (ALDH) activity, characteristic of cancer and stem cells, is a property of LAM cells. METHODS: We performed an in silico search of ALDH genes in microdissected LAM lung nodules. To identify circulating LAM cells, we osmotically removed red blood cells from whole blood to obtain peripheral blood mononuclear cells, which were then sorted by fluorescence-activated cell sorting based on their level of ALDH activity. RESULTS: Microdissected LAM lung nodules possess a distinctive ALDH gene profile. The cell subpopulation with high ALDH activity, isolated from circulating cells, possessed TSC2 LOH in 8 of 14 patients with LAM. Approximately 60% of the circulating cells with high ALDH activity expressed CD44v6. Cells with TSC2 LOH from patients with LAM and LAM/TSC exhibited different properties in different body locations, but all cell types showed high ALDH activity. CONCLUSIONS: This new procedure allows for isolation of circulating LAM cells from cultured cells, blood, and chylous effusions and shows that circulating LAM cells are heterogeneous with neoplastic, metastatic, and cancer-stem cell-like properties.
Authors: Wendy K Steagall; Li Zhang; Xiong Cai; Gustavo Pacheco-Rodriguez; Joel Moss Journal: Am J Respir Crit Care Med Date: 2015-04-01 Impact factor: 21.405
Authors: John P Chute; Garrett G Muramoto; John Whitesides; Michael Colvin; Rachid Safi; Nelson J Chao; Donald P McDonnell Journal: Proc Natl Acad Sci U S A Date: 2006-07-20 Impact factor: 11.205
Authors: A M S Cheung; T S K Wan; J C K Leung; L Y Y Chan; H Huang; Y L Kwong; R Liang; A Y H Leung Journal: Leukemia Date: 2007-05-03 Impact factor: 11.528
Authors: Gustavo Pacheco-Rodriguez; Wendy K Steagall; Denise M Crooks; Linda A Stevens; Hiroshi Hashimoto; Shaowei Li; Ji-an Wang; Thomas N Darling; Joel Moss Journal: Cancer Res Date: 2007-11-01 Impact factor: 12.701
Authors: Xavier Farré; Roderic Espín; Alexandra Baiges; Eline Blommaert; Wonji Kim; Krinio Giannikou; Carmen Herranz; Antonio Román; Berta Sáez; Álvaro Casanova; Julio Ancochea; Claudia Valenzuela; Piedad Ussetti; Rosalía Laporta; José A Rodríguez-Portal; Coline H M van Moorsel; Joanne J van der Vis; Marian J R Quanjel; Mireia Tena-Garitaonaindia; Fermín Sánchez de Medina; Francesca Mateo; María Molina-Molina; Sungho Won; David J Kwiatkowski; Rafael de Cid; Miquel Angel Pujana Journal: ERJ Open Res Date: 2022-01-24
Authors: Carmen Herranz; Francesca Mateo; Alexandra Baiges; Gorka Ruiz de Garibay; Alexandra Junza; Simon R Johnson; Suzanne Miller; Nadia García; Jordi Capellades; Antonio Gómez; August Vidal; Luis Palomero; Roderic Espín; Ana I Extremera; Eline Blommaert; Eva Revilla-López; Berta Saez; Susana Gómez-Ollés; Julio Ancochea; Claudia Valenzuela; Tamara Alonso; Piedad Ussetti; Rosalía Laporta; Antoni Xaubet; José A Rodríguez-Portal; Ana Montes-Worboys; Carlos Machahua; Jaume Bordas; Javier A Menendez; Josep M Cruzado; Roser Guiteras; Christophe Bontoux; Concettina La Motta; Aleix Noguera-Castells; Mario Mancino; Enrique Lastra; Raúl Rigo-Bonnin; Jose C Perales; Francesc Viñals; Alvaro Lahiguera; Xiaohu Zhang; Daniel Cuadras; Coline H M van Moorsel; Joanne J van der Vis; Marian J R Quanjel; Harilaos Filippakis; Razq Hakem; Chiara Gorrini; Marc Ferrer; Aslihan Ugun-Klusek; Ellen Billett; Elżbieta Radzikowska; Álvaro Casanova; María Molina-Molina; Antonio Roman; Oscar Yanes; Miquel A Pujana Journal: EMBO Mol Med Date: 2021-08-11 Impact factor: 12.137
Authors: Roderic Espín; Alexandra Baiges; Eline Blommaert; Carmen Herranz; Antonio Roman; Berta Saez; Julio Ancochea; Claudia Valenzuela; Piedad Ussetti; Rosalía Laporta; José A Rodríguez-Portal; Coline H M van Moorsel; Joanne J van der Vis; Marian J R Quanjel; Anna Villar-Piqué; Daniela Diaz-Lucena; Franc Llorens; Álvaro Casanova; María Molina-Molina; Mireya Plass; Francesca Mateo; Joel Moss; Miquel Angel Pujana Journal: Mol Cancer Res Date: 2021-07-26 Impact factor: 6.333